Open AccessMyeloproliferative neoplasms
Author(s) -
Neysimelia Costa Villela,
G Zamperlini,
Patrícia Shimoda Ikeuti,
Roseane Vasconcelos Gouveia,
Simone de Castro Resende Franco,
Luiz Fernando Lopes
Publication year - 2021
Publication title -
journal of bone marrow transplantation and cellular therapy
Language(s) - English
Resource type - Journals
ISSN - 2675-374X
DOI - 10.46765/2675-374x.2021v2n4p129
Subject(s) - myelofibrosis , essential thrombocythemia , polycythemia vera , medicine , myeloproliferative disorders , myeloid leukemia , myeloproliferative neoplasm , incidence (geometry) , anagrelide , bone marrow , physics , optics
In addition to the chronic myeloid leukemia (CML) BCR-ABL1+, classic myeloproliferative neoplasms include polycythemia vera, essential thrombocythemia and primary myelofibrosis. These have a very low incidence in the pediatric age group and there is no consensus on treatment in children.